Kisspeptin

⏱ Half-Life

Short duration profile

Kisspeptin demonstrates a short half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.

⚡ Onset Characteristics

Fast measurable response

Onset is observed as fast — a property that influences how researchers structure comparative studies versus other compounds in the signalling research category.

🧠 Key Notes

What makes it distinct

• 01Encoded by the KISS1 gene
• 02Primary upstream trigger of GnRH neurons
• 03Central to puberty onset and fertility research

🧬 Mechanism of Action

How it works

Kisspeptin binds the GPR54 (KISS1R) receptor on hypothalamic GnRH neurons, triggering pulsatile release of gonadotropin-releasing hormone. This in turn drives pituitary secretion of LH and FSH, which regulate gonadal steroidogenesis and gametogenesis. Kisspeptin sits at the apex of the hypothalamic-pituitary-gonadal (HPG) axis and integrates metabolic, circadian, and steroid-feedback signals into reproductive output. Loss-of-function KISS1R mutations cause hypogonadotropic hypogonadism, confirming kisspeptin's non-redundant role in reproductive activation.

✨ Documented Benefits

What the research shows it supports

🔍 Research Insights

What the literature shows

🧪 Typical Research Use Cases

Where it appears in study design

📚 References

Peer-reviewed literature

Primary research sources cited on this profile. All links resolve to PubMed or the publishing journal.

1. [01]

   de Roux, N. et al. (2003). Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. PNAS, 100(19), 10972–10976.

   Proceedings of the National Academy of Sciences ↗
2. [02]

   Dhillo, W. S. et al. (2005). Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. Journal of Clinical Endocrinology & Metabolism, 90(12), 6609–6615.

   Journal of Clinical Endocrinology & Metabolism ↗
3. [03]

   Abbara, A. et al. (2015). Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS). Journal of Clinical Endocrinology & Metabolism, 100(9), 3322–3331.

   Journal of Clinical Endocrinology & Metabolism ↗
4. [04]

   Skorupskaite, K. et al. (2014). The kisspeptin-GnRH pathway in human reproductive health and disease. Human Reproduction Update, 20(4), 485–500.

   Human Reproduction Update ↗